Novel approaches to locally advanced unresectable non-small cell lung cancer
- 1 April 2000
- journal article
- review article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 55 (1), 11-18
- https://doi.org/10.1016/s0167-8140(00)00163-8
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Pulmonary injury from proton and conventional radiotherapy as revealed by CT.American Journal of Roentgenology, 1999
- Results of a phase II concurrent chemoradiotherapy study using three-dimensional conformal radiotherapy with cisplatin and oral etoposide in stage III nonsmall-cell lung cancerRadiation Oncology Investigations, 1999
- Gene expression informatics —it's all in your mineNature Genetics, 1999
- Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer.Journal of Clinical Oncology, 1998
- Target volume definition for three-dimensional conformal radiation therapy of lung cancer.The British Journal of Radiology, 1998
- Exploiting tumour hypoxia and overcoming mutant p53 with tirapazamine.British Journal of Cancer, 1998
- Phase I Study of Tirapazamine and Cisplatin in Patients with Recurrent Cervical CancerGynecologic Oncology, 1997
- Direct Intratumoral Injection of an Adenovirus Expressing Interleukin-12 Induces Regression and Long-Lasting Immunity That Is Associated with Highly Localized Expression of Interleukin-12Human Gene Therapy, 1996
- Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805.Journal of Clinical Oncology, 1995
- SR 4233 (Tirapazamine): a new anticancer drug exploiting hypoxia in solid tumoursBritish Journal of Cancer, 1993